Transplantation · 1996 · 42 citations · 5 references
PharmacyPharmacokineticsPharmacologyCircadian RhythmsPharmacokinetic VariabilityPopulation PharmacokineticsCircadian PharmacologyDrug DispositionInterindividual VariabilityPharmacokinetics In Liver DiseaseTime To Peak AnalysisTime-dependent PharmacokineticsCircadian Drug TimingLiver Circadian RhythmsPharmacokinetic ParametersPharmacokinetic RhythmsSteady-state DistributionTacrolimus PharmacokineticsTacrolimus Therapy
The aim of this study was to characterize the circadian variation of oral tacrolimus disposition in 8 stable liver allograft recipients. In the steady state, a total of 23 blood samples was taken before and after tacrolimus administration during a 24-hr period and the pharmacokinetic parameters were compared. The area under the curve (AUC) of tacrolimus after the morning dose was significantly larger than after the evening dose (211+/-43 ng x hr/ml [morning] vs. 179+/-45 ng x hr/ml [evening], P=0.02). The time to peak (Tmax) was significantly shorter after the morning dose than after the evening dose (1.6+/-0.7 hr [morning] vs. 2.9+/-0.6 hr [evening], P=0.002). The peak (Cmax) was significantly higher after the morning dose than after the evening dose (32.2+/-10.2 ng/ml [morning] vs. 19.1+/-4.3 ng/ml [evening], P=0.003). However, the trough (Cmin) was not significantly different between the morning dose and the evening dose (13.1+/-3.9 ng/ml [morning] vs. 13.3+/-4.4 ng/ml [evening], P=0.4). This study demonstrated that tacrolimus disposition in liver transplant patients was determined by administration time.
5
Possible effect of time on renal allograft rejection.
M S Knapp, J R Cove-Smith, R Dugdale et al. · BMJ · 1979 · 46 citations · Full text
Medicine, Nephrology, Physiology +12
Robert J. Cipolle, Daniel M. Canafax, Jeff Rabatin et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1988 · 22 citations